Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
SAB Biotherapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||
Fees Previously Paid | Equity | Common Stock, par value $0.0001 per share underlying Warrants | 457(g) | 300,000 | $ | 0.5424 | (2) | $ | 162,720 | 0.0001102 | $ | 17.93 | ||||||||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | 457(c) | 1,916,894 | $ | 0.82 | (3) | $ | 1,571,853 | 0.0001102 | $ | 173.22 | ||||||||||||||
Total Offering Amounts | $ | 1,734,573 | $ | 191.15 | ||||||||||||||||||||||
Total Fees Previously Paid | $ | 162,720 | 17.93 | |||||||||||||||||||||||
Total Fee Offsets | — | |||||||||||||||||||||||||
Net Fee Due | $ | 1,571,853 | $ | 173.22 |
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the common shares offered hereby and the common shares issuable upon exercise of warrants also include an indeterminate number of additional common shares as may from time to time become issuable by reason of share splits, share dividends, recapitalizations or other similar transactions. |
(2) | With respect to the common stock underlying the warrants offered by the selling stockholders, $0.5424 per share, which is the exercise price of the warrants, for purposes of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. |
(3) | Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based on average of high and low price per share of the common stock on July 5, 2023. |